# Helix Acquisition Corp. III (HLXC)

**Exchange:** NASDAQ  
**Sector:** Financial Services  
**Price:** $10.26 (-0.19%)

> Helix Acquisition Corp. III is a blank check company, structured as a special purpose acquisition company (SPAC), incorporated in the Cayman Islands in 2025. Its primary purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses, with a strategic focus on the healthcare and healthcare-related industries, including biotech, medtech, and life sciences sectors. Sponsored by Helix Holdings III LLC, an affiliate of Cormorant Asset Management, the company recently priced an upsized initial public offering of 15 million Class A ordinary shares at $10 each, raising $150 million, which underscores its capacity to pursue significant opportunities in these specialized fields. Leadership includes Chairperson and Chief Executive Officer Bihua Chen, founder of Cormorant Asset Management; Chief Financial Officer and Chief Operating Officer Caleb Tripp; and Chief Legal Officer Nebojsa Obradovic, bringing deep expertise in healthcare investments. Headquartered at 200 Clarendon Street, 52nd Floor, Boston, MA, Helix Acquisition Corp. III plays a key role in facilitating public market access for innovative healthcare entities through efficient SPAC transactions. Prior SPACs from the team, such as Helix Acquisition Corp. II and Helix Acquisition Corp., have successfully merged with oncology biotech and immunotherapy companies, highlighting a proven track record in the sector.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/HLXC)